Answers are grounded in this paper and cite their sources.
CXL is a promising option for treating patients with therapy-refractory infectious keratitis to avoid emergency keratoplasty.
No takes yet. Share an insight, caveat, or question.
Iseli et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: